Results 1 to 10 of about 226 (76)

Surgical treatment of uveal melanoma: Exoresection versus endoresection [PDF]

open access: yesTaiwan Journal of Ophthalmology
Uveal melanoma, the most common primary intraocular malignancy in adults, presents significant therapeutic challenges. With the advancement of surgical instruments and techniques, exoresection (ab-externo) and endoresection (ab-interno) have emerged as ...
Seung Min Lee, Min Kim
doaj   +4 more sources

Surgical Approach in Intraocular Tumors [PDF]

open access: yesTürk Oftalmoloji Dergisi, 2022
Surgery in intraocular tumors is done for excision/biopsy and the management of complications secondary to the treatment of these tumors. Excision/biopsy of intraocular tumors can be done via fine-needle aspiration biopsy (FNAB), transretinal biopsy (TRB)
Ahmet Kaan Gündüz, Ibadulla Mirzayev
doaj   +2 more sources

Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma. [PDF]

open access: yesCancer Rep (Hoboken)
ABSTRACT Background Uveal melanoma (UM) is the prevailing malignant tumor that develops within the eye in adults, and it has a bleak outlook because of the few treatment choices available and the high likelihood of returning after treatment. Currently, surgical intervention, radiation therapy, and a combination of both modalities are available ...
Azani A   +13 more
europepmc   +2 more sources

Current management of uveal melanoma: A review

open access: yesClinical &Experimental Ophthalmology, Volume 51, Issue 5, Page 484-494, July 2023., 2023
Abstract Uveal melanoma is the most frequent primary intraocular cancer in adulthood and is mostly localised to the choroid. It can be treated using radiation therapy, laser therapy, local resection and enucleation, with the best results achieved by combining these procedures. However, up to half of patients develop metastatic disease.
Haixia Bai   +2 more
wiley   +1 more source

Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention

open access: yesThe Journal of Pathology: Clinical Research, Volume 8, Issue 4, Page 383-394, July 2022., 2022
Abstract Uveal melanoma (UM) is the most common intraocular cancer in adults. Whilst treatment of primary UM (PUM) is often successful, around 50% of patients develop metastatic disease with poor outcomes, linked to chromosome 3 loss (monosomy 3, M3). Advances in understanding UM cell biology may indicate new therapeutic options.
Dorota Sabat‐Pośpiech   +6 more
wiley   +1 more source

Early detection of metastatic uveal melanoma by the analysis of tumor‐specific mutations in cell‐free plasma DNA

open access: yesCancer Medicine, Volume 10, Issue 17, Page 5974-5982, September 2021., 2021
In metastasized uveal melanoma (UM) patients, circulating tumor DNA (ctDNA) can be detected in blood. Here we explored if cfDNA is a suitable biomarker for the early detection of metastatic disease in UM patients. Our data show that this biomarker fulfills the expectation as, overall, about half of the patients who developed metastases showed a ...
Claudia H. D. Le Guin   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy